Medicines for Malaria Venture
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Medicines for Malaria Venture
The CEO of QuantumDX, Jonathan O’Halloran, spoke to Medtech Insight about the benefits of selling diagnostics in China and argued for a pragmatic approach to IP protection when launching in a country where counterfeiting is common.
China's CSPC Pharmaceutical Group surprises by announcing investigator-initiated trial results for SYS6006, its mRNA COVID-19 vaccine candidate against the Omicron variant.
As the Communist Party of China gears up for its once in every five years National Congress late this fall, the need for more novel drugs to help address the persistent coronavirus pandemic is rising amid the country’s strict “COVID Zero” policies.
Chinese biotechs have reached deals for cancer therapies to explore the novel uses of messenger RNA technology beyond COVID-19 vaccines, as the mRNA COVID-19 vaccine fame starts fading.
- Academic and Research Institutions